Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6077833A · kind A · utility
28Cited by
22References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 31, 1996 |
| Grant date | Jun 20, 2000 |
| Priority date | — |
| Expiry date | Dec 31, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the diagnosis, prevention and treatment of immune states and disorders amenable to treatment through modulation of T cell activation are provided. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding B7 proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.